Group One Trading’s Ambrx Biopharma Inc AMAM Stock Holding History

Group One Trading’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38,800	Closed	-$553K	–	8223
2023 Q4	$553K	Sell	38,800 -56,300	-59%	-$640K	﹤0.01%	2987
2023 Q3	$1.09M	Buy	95,100 +44,600	+88%	+$607K	﹤0.01%	2172
2023 Q2	$831K	Buy	50,500 +19,300	+62%	+$243K	﹤0.01%	2526
2023 Q1	$278K	Buy	31,200 +17,400	+126%	+$87.4K	﹤0.01%	3358
2022 Q4	$31.3K	Buy	+13,800	New	+$15.8K	﹤0.01%	5314

Group One Trading's AMAM Position: Q4 2023 in Review

Group One Trading sold out of Ambrx Biopharma Inc (AMAM) in Q4 2023, closing a stake of 2,155 shares — an estimated $24.5K sold.

Group One Trading first reported a position in AMAM in Q1 2023 and held it in 2 quarters. The position peaked at $29.8K in Q1 2023. 68 funds tracked by Wall St. Rank hold AMAM as of Q4 2023.

Group One Trading reported no remaining Ambrx Biopharma Inc position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 2,155 Ambrx Biopharma Inc shares in Q4 2023, an estimated $24.5K.
Group One Trading first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 2 quarters.
Group One Trading's Ambrx Biopharma Inc position peaked at $29.8K in Q1 2023.
68 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.